Carson Advisory Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,178 shares of the healthcare conglomerate’s stock after buying an additional 59 shares during the quarter. Carson Advisory Inc.’s holdings in UnitedHealth Group were worth $596,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. SageView Advisory Group LLC increased its holdings in shares of UnitedHealth Group by 13.4% in the fourth quarter. SageView Advisory Group LLC now owns 10,487 shares of the healthcare conglomerate’s stock valued at $5,305,000 after purchasing an additional 1,243 shares in the last quarter. Keystone Financial Group increased its stake in shares of UnitedHealth Group by 16.9% in the 4th quarter. Keystone Financial Group now owns 2,644 shares of the healthcare conglomerate’s stock valued at $1,343,000 after buying an additional 382 shares during the period. Savvy Advisors Inc. lifted its stake in shares of UnitedHealth Group by 31.4% during the fourth quarter. Savvy Advisors Inc. now owns 4,352 shares of the healthcare conglomerate’s stock valued at $2,202,000 after acquiring an additional 1,040 shares during the period. Stamos Capital Partners L.P. increased its position in UnitedHealth Group by 17.2% in the fourth quarter. Stamos Capital Partners L.P. now owns 9,950 shares of the healthcare conglomerate’s stock worth $5,033,000 after purchasing an additional 1,460 shares during the period. Finally, Sanders Capital LLC lifted its position in UnitedHealth Group by 1.2% during the 4th quarter. Sanders Capital LLC now owns 5,258,593 shares of the healthcare conglomerate’s stock valued at $2,660,112,000 after purchasing an additional 61,991 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
Shares of UNH stock opened at $599.10 on Friday. The firm has a market cap of $548.00 billion, a PE ratio of 38.65, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company’s fifty day simple moving average is $512.87 and its 200-day simple moving average is $542.03. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the company earned $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s payout ratio is 54.19%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- How to Short a Stock in 5 Easy Steps
- Is McDonald’s Stock Serving a Value Meal to Investors?
- Growth Stocks: What They Are, What They Are Not
- Walgreens Comeback? Private Equity Circling for a Buyout
- Market Cap Calculator: How to Calculate Market Cap
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.